PATHOLOGICAL CHANGES DEVELOPING IN THE RAT DURING A 3-WEEK COURSE OF HIGH DOSAGE CYCLOSPORIN A AND THEIR REVERSAL FOLLOWING DRUG WITHDRAWAL
- 1 October 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 32 (4) , 271-277
- https://doi.org/10.1097/00007890-198110000-00002
Abstract
Adult Sprague-Dawley rats given [the immunologic drug] cyclosporin A (Cy A) orally in a dose of 100 mg/kg every 48 h for 21 days displayed pronounced suppression of humoral immunity to sheep red blood cells. They showed hair loss and failure to gain weight and exhibited a progressive increase in serum urea, serum creatinine and urinary N-acetyl-.beta.-D-glucosaminidase (NAG) activity, with a fall in urea clearance rate. Hypoalbuminemia and hyperbilirubinemia were observed in combination with a significant decrease in serum aspartate aminotransferase (AAT) and alkaline phosphatase levels. At 2 wk there was significant lymphopenia with the appearance of atypical lymphocytes in the peripheral blood. Autopsies performed on animals killed at 3 wk revealed no light microscopic or ultrastructural differences between test and control animals, apart from some reduction in overall bone marrow cellularity in the former. During the 3 wk period following withdrawal of Cy A, renal and hepatic function reverted to normal and a rebound lymphocytosis occurred. Only 1 of 6 rats autopsied 3 wk after cessation of Cy A administration showed reduced bone marrow cellularity. The rat may be a useful experimental model for further investigation of the functional and structural changes which may be encountered in the clinical use of Cy A.This publication has 14 references indexed in Scilit:
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Serum and urine in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabeticsClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- CYCLOSPORIN-A - INVIVO AND INVITRO SUPPRESSION OF RAT T-LYMPHOCYTE FUNCTION1979
- CYCLOSPORIN ATransplantation, 1979
- CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MANThe Lancet, 1978
- PROLONGED SURVIVAL OF PIG ORTHOTOPIC HEART GRAFTS TREATED WITH CYCLOSPORIN AThe Lancet, 1978
- EXTENSIVE PROLONGATION OF RABBIT KIDNEY ALLOGRAFT SURVIVAL AFTER SHORT-TERM CYCLOSPORIN-A TREATMENTThe Lancet, 1978
- EFFECTS OF NEW ANTI-LYMPHOCYTIC PEPTIDE CYCLOSPORIN-A IN ANIMALS1977
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976